Can molecular insights guide treatment of AML evolved from MPNs?

Best Pract Res Clin Haematol

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 443, New York, NY, 10022, USA.

Published: December 2021

Leukemic transformation of myeloproliferative neoplasms (MPNs) is associated with dismal outcomes. The genetic complexity of leukemic transformation of MPNs is being deciphered and will likely result in targeted therapy approaches. Ongoing trials are investigating the efficacy of emerging treatments for this high-risk patient population. This review has outlined recent progress in the understanding and treatment of leukemia arising from MPNs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2021.101323DOI Listing

Publication Analysis

Top Keywords

leukemic transformation
8
molecular insights
4
insights guide
4
guide treatment
4
treatment aml
4
aml evolved
4
evolved mpns?
4
mpns? leukemic
4
transformation myeloproliferative
4
myeloproliferative neoplasms
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!